{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T09:07:48Z","timestamp":1789031268399,"version":"build-2803163510"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,10]]},"DOI":"10.7759\/cureus.116035","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T08:17:15Z","timestamp":1789028235000},"source":"Crossref","is-referenced-by-count":0,"title":["Lamotrigine-Associated Visual and Tactile Hallucinations in a Patient With Bipolar Disorder: A Case Report"],"prefix":"10.7759","author":[{"given":"B\u00e1rbara","family":"Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Morais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrique","family":"Salgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12609","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder","volume":"20","author":"Yatham LN","year":"2018","unstructured":"Yatham LN, Kennedy SH, Parikh SV, et al.. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018, 20:97-170. 10.1111\/bdi.12609","journal-title":"Bipolar Disord"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.59.6.530","article-title":"The long-term natural history of the weekly symptomatic status of bipolar I disorder","volume":"59","author":"Judd LL","year":"2002","unstructured":"Judd LL, Akiskal HS, Schettler PJ, et al.. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry. 2002, 59:530-7. 10.1001\/archpsyc.59.6.530","journal-title":"Arch Gen Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.107.048504","article-title":"Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials","volume":"194","author":"Geddes JR","year":"2009","unstructured":"Geddes JR, Calabrese JR, Goodwin GM. Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br J Psychiatry. 2009, 194:4-9. 10.1192\/bjp.bp.107.048504","journal-title":"Br J Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12984","article-title":"Pharmacokinetics of lamotrigine and its metabolite N-2-glucuronide: influence of polymorphism of UDP-glucuronosyltransferases and drug transporters","volume":"82","author":"Milosheska D","year":"2016","unstructured":"Milosheska D, Lorber B, Vovk T, Kastelic M, Dol\u017ean V, Grabnar I. Pharmacokinetics of lamotrigine and its metabolite N-2-glucuronide: influence of polymorphism of UDP-glucuronosyltransferases and drug transporters. Br J Clin Pharmacol. 2016, 82:399-411. 10.1111\/bcp.12984","journal-title":"Br J Clin Pharmacol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1992.tb04079.x","article-title":"Sodium valproate acutely inhibits lamotrigine metabolism","volume":"33","author":"Yuen AW","year":"1992","unstructured":"Yuen AW, Land G, Weatherley BC, Peck AW. Sodium valproate acutely inhibits lamotrigine metabolism. Br J Clin Pharmacol. 1992, 33:511-3. 10.1111\/j.1365-2125.1992.tb04079.x","journal-title":"Br J Clin Pharmacol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2007.03.015","article-title":"Development of psychosis in patients with epilepsy treated with lamotrigine: report of six cases and review of the literature","volume":"11","author":"Brandt C","year":"2007","unstructured":"Brandt C, Fueratsch N, Boehme V, et al.. Development of psychosis in patients with epilepsy treated with lamotrigine: report of six cases and review of the literature. Epilepsy Behav. 2007, 11:133-9. 10.1016\/j.yebeh.2007.03.015","journal-title":"Epilepsy Behav"},{"key":"ref7","article-title":"Lamotrigine-induced hallucination in patient with bipolar disorder and no history of epilepsy or psychosis: a case report and literature review","volume":"7","author":"Hameed Y","year":"2014","unstructured":"Hameed Y, Hamelijnck J. Lamotrigine-induced hallucination in patient with bipolar disorder and no history of epilepsy or psychosis: a case report and literature review. Br J Med Pract. 2014, 7:a714.","journal-title":"Br J Med Pract"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.14cr09099","article-title":"Lamotrigine-induced tactile hallucination","volume":"75","author":"Oh HK","year":"2014","unstructured":"Oh HK, Tibrewal P, Dhillon R. Lamotrigine-induced tactile hallucination. J Clin Psychiatry. 2014, 75:e1330. 10.4088\/JCP.14cr09099","journal-title":"J Clin Psychiatry"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2018.11.004","article-title":"Complex hallucinations induced by lamotrigine","volume":"175","author":"El Otmani H","year":"2019","unstructured":"El Otmani H, Amzil R, Rafai MA, El Moutawakil B. Complex hallucinations induced by lamotrigine. Rev Neurol (Paris). 2019, 175:410-1. 10.1016\/j.neurol.2018.11.004","journal-title":"Rev Neurol (Paris)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.163.4.749-a","article-title":"Hallucinations during lamotrigine treatment of bipolar disorder","volume":"163","author":"Uher R","year":"2006","unstructured":"Uher R, Jones HM. Hallucinations during lamotrigine treatment of bipolar disorder. Am J Psychiatry. 2006, 163:749-50. 10.1176\/appi.ajp.163.4.749-a","journal-title":"Am J Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-016-0219-z","article-title":"Drug-induced tactile hallucinations beyond recreational drugs","volume":"17","author":"Nakamura M","year":"2016","unstructured":"Nakamura M, Koo J. Drug-induced tactile hallucinations beyond recreational drugs. Am J Clin Dermatol. 2016, 17:643-52. 10.1007\/s40257-016-0219-z","journal-title":"Am J Clin Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.20230329","article-title":"Risk of incident psychosis and mania with prescription amphetamines","volume":"181","author":"Moran LV","year":"2024","unstructured":"Moran LV, Skinner JP, Shinn AK, et al.. Risk of incident psychosis and mania with prescription amphetamines. Am J Psychiatry. 2024, 181:901-9. 10.1176\/appi.ajp.20230329","journal-title":"Am J Psychiatry"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1159\/000026527","article-title":"Cellular and molecular actions of lamotrigine: possible mechanisms of efficacy in bipolar disorder","volume":"38","author":"Xie X","year":"1998","unstructured":"Xie X, Hagan RM. Cellular and molecular actions of lamotrigine: possible mechanisms of efficacy in bipolar disorder. Neuropsychobiology. 1998, 38:119-30. 10.1159\/000026527","journal-title":"Neuropsychobiology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2003.09.008","article-title":"Evaluation of VPA dose and concentration effects on lamotrigine pharmacokinetics: implications for conversion to lamotrigine monotherapy","volume":"57","author":"Gidal BE","year":"2003","unstructured":"Gidal BE, Sheth R, Parnell J, Maloney K, Sale M. Evaluation of VPA dose and concentration effects on lamotrigine pharmacokinetics: implications for conversion to lamotrigine monotherapy. Epilepsy Res. 2003, 57:85-93. 10.1016\/j.eplepsyres.2003.09.008","journal-title":"Epilepsy Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-45. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/525584-lamotrigine-associated-visual-and-tactile-hallucinations-in-a-patient-with-bipolar-disorder-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T08:17:16Z","timestamp":1789028236000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/525584-lamotrigine-associated-visual-and-tactile-hallucinations-in-a-patient-with-bipolar-disorder-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.116035","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,10]]}}}